Jennifer R Charlton1, Louis Boohaker2, David Askenazi2, Patrick D Brophy3, Carl D'Angio3, Mamta Fuloria4, Jason Gien5, Russell Griffin2, Sangeeta Hingorani6, Susan Ingraham7, Ayesa Mian3, Robin K Ohls8, Shantanu Rastogi9, Christopher J Rhee10, Mary Revenis11, Subrata Sarkar12, Alexandra Smith13, Michelle Starr6, Alison L Kent3. 1. University of Virginia, Charlottesville, Virginia; jrc6n@virginia.edu. 2. University of Alabama at Birmingham, Birmingham, Alabama. 3. Golisano Children's Hospital, University of Rochester, Rochester, New York. 4. Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, New York. 5. Children's Hospital Colorado, University of Colorado, Aurora, Colorado. 6. Seattle Children's Hospital/University of Washington, Seattle, Washington. 7. Kapi'olani Medical Center for Women and Children, Honolulu, Hawaii. 8. University of New Mexico, Albuquerque, New Mexico. 9. Maimonides Infants and Children's Hospital, Brooklyn, New York. 10. Texas Children's Hospital, Baylor College of Medicine, Houston, Texas. 11. Children's National Medical Center, The George Washington University School of Medicine and The Health Sciences, Washington, DC. 12. C.S. Mott Children's Hospital, University of Michigan, Ann Arbor, Michigan; and. 13. Tufts University School of Medicine, Boston, Massachusetts.
Abstract
BACKGROUND AND OBJECTIVES: Neonatal AKI is associated with poor short- and long-term outcomes. The objective of this study was to describe the risk factors and outcomes of neonatal AKI in the first postnatal week. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The international retrospective observational cohort study, Assessment of Worldwide AKI Epidemiology in Neonates (AWAKEN), included neonates admitted to a neonatal intensive care unit who received at least 48 hours of intravenous fluids. Early AKI was defined by an increase in serum creatinine >0.3 mg/dl or urine output <1 ml/kg per hour on postnatal days 2-7, the neonatal modification of Kidney Disease: Improving Global Outcomes criteria. We assessed risk factors for AKI and associations of AKI with death and duration of hospitalization. RESULTS: Twenty-one percent (449 of 2110) experienced early AKI. Early AKI was associated with higher risk of death (adjusted odds ratio, 2.8; 95% confidence interval, 1.7 to 4.7) and longer duration of hospitalization (parameter estimate: 7.3 days 95% confidence interval, 4.7 to 10.0), adjusting for neonatal and maternal factors along with medication exposures. Factors associated with a higher risk of AKI included: outborn delivery; resuscitation with epinephrine; admission diagnosis of hyperbilirubinemia, inborn errors of metabolism, or surgical need; frequent kidney function surveillance; and admission to a children's hospital. Those factors that were associated with a lower risk included multiple gestations, cesarean section, and exposures to antimicrobials, methylxanthines, diuretics, and vasopressors. Risk factors varied by gestational age strata. CONCLUSIONS: AKI in the first postnatal week is common and associated with death and longer duration of hospitalization. The AWAKEN study demonstrates a number of specific risk factors that should serve as "red flags" for clinicians at the initiation of the neonatal intensive care unit course.
BACKGROUND AND OBJECTIVES: Neonatal AKI is associated with poor short- and long-term outcomes. The objective of this study was to describe the risk factors and outcomes of neonatal AKI in the first postnatal week. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The international retrospective observational cohort study, Assessment of Worldwide AKI Epidemiology in Neonates (AWAKEN), included neonates admitted to a neonatal intensive care unit who received at least 48 hours of intravenous fluids. Early AKI was defined by an increase in serum creatinine >0.3 mg/dl or urine output <1 ml/kg per hour on postnatal days 2-7, the neonatal modification of Kidney Disease: Improving Global Outcomes criteria. We assessed risk factors for AKI and associations of AKI with death and duration of hospitalization. RESULTS: Twenty-one percent (449 of 2110) experienced early AKI. Early AKI was associated with higher risk of death (adjusted odds ratio, 2.8; 95% confidence interval, 1.7 to 4.7) and longer duration of hospitalization (parameter estimate: 7.3 days 95% confidence interval, 4.7 to 10.0), adjusting for neonatal and maternal factors along with medication exposures. Factors associated with a higher risk of AKI included: outborn delivery; resuscitation with epinephrine; admission diagnosis of hyperbilirubinemia, inborn errors of metabolism, or surgical need; frequent kidney function surveillance; and admission to a children's hospital. Those factors that were associated with a lower risk included multiple gestations, cesarean section, and exposures to antimicrobials, methylxanthines, diuretics, and vasopressors. Risk factors varied by gestational age strata. CONCLUSIONS: AKI in the first postnatal week is common and associated with death and longer duration of hospitalization. The AWAKEN study demonstrates a number of specific risk factors that should serve as "red flags" for clinicians at the initiation of the neonatal intensive care unit course.
Authors: Alison L Kent; Rebecca Douglas-Denton; Bruce Shadbolt; Jane E Dahlstrom; Lesley E Maxwell; Mark E Koina; Michael C Falk; David Willenborg; John F Bertram Journal: Pediatr Nephrol Date: 2009-02-24 Impact factor: 3.714
Authors: Susan E Jacobs; Marie Berg; Rod Hunt; William O Tarnow-Mordi; Terrie E Inder; Peter G Davis Journal: Cochrane Database Syst Rev Date: 2013-01-31
Authors: Matthew W Harer; David T Selewski; Kianoush Kashani; Rajit K Basu; Katja M Gist; Jennifer G Jetton; Scott M Sutherland; Michael Zappitelli; Stuart L Goldstein; Theresa Ann Mottes; David J Askenazi Journal: J Perinatol Date: 2020-09-05 Impact factor: 2.521
Authors: Aurélie De Mul; Paloma Parvex; Alice Héneau; Valérie Biran; Antoine Poncet; Olivier Baud; Marie Saint-Faust; Alexandra Wilhelm-Bals Journal: Clin J Am Soc Nephrol Date: 2022-06-28 Impact factor: 10.614
Authors: Arwa Nada; David Askenazi; Juan C Kupferman; Maroun Mhanna; John D Mahan; Louis Boohaker; Linzi Li; Russell L Griffin Journal: Pediatr Nephrol Date: 2021-10-18 Impact factor: 3.651
Authors: Sangeeta Hingorani; Robert H Schmicker; Patrick D Brophy; Patrick J Heagerty; Sandra E Juul; Stuart L Goldstein; David Askenazi Journal: Clin J Am Soc Nephrol Date: 2021-06-11 Impact factor: 10.614